MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fcvm.2026.1944441

Медицинская библиотека · Frontiers in cardiovascular medicine · 2026

Short- and mid-term outcomes of mitral valve repair vs. replacement in degenerative mitral regurgitation with left ventricular enlargement.

Wu Chun, Sheng Zhe, Hu Jianhao, Liu Yuyong, Zhang Chengxin, Xu Jinguo

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

This study evaluates short- to mid-term outcomes following mitral valve repair (MVP) and mitral valve replacement (MVR) among patients with degenerative mitral regurgitation (DMR) complicated by substantial left ventricular dilatation (LVD).

METHODS

We performed a retrospective analysis enrolling 150 patients diagnosed with DMR and severe LVD who received either MVP or MVR. The median clinical follow-up duration was 55.5 (21.0) months. Propensity score matching (PSM) was conducted to eliminate intergroup baseline disparities. Kaplan-Meier survival curves were generated to estimate short- and mid-term all-cause survival.

RESULTS

Of the 150 enrolled patients with DMR and marked left ventricular dilatation, 56.67% underwent MVR and 43.33% received MVP. The cohort had a median age of 59 (17) years, with female patients making up 23.3% of participants. Preoperative atrial fibrillation occurred in 15.33% of patients, and 92.05% presented with severe baseline mitral valve regurgitation (MR). Analyses before and after PSM showed similar postoperative left ventricular end-diastolic dimension (LVEDD) and New York Heart Association functional class across groups. Significant intergroup differences were detected in postoperative MR (P = 0.017), left ventricular ejection fraction (LVEF) (P = 0.005), and global longitudinal strain (GLS) (P = 0.023). Kaplan-Meier curves indicated equivalent postoperative survival for patients who underwent MVP and MVR both before matching (log-rank P = 0.175) and after PSM matching (log-rank P = 0.497).

CONCLUSIONS

In patients with DMR and dilated left ventricles (≥6.0 cm), MVR was associated with a greater incidence of postoperative hemorrhage related to long-term oral anticoagulation, whereas MVP conferred a higher risk of recurrent MR. Postoperative mortality was comparable across cohorts; however, preserved left ventricular subclinical systolic function (GLS and LVEF) in the MVP group suggests potential long-term myocardial benefits, which warrants further prospective investigation.

Для цитирования: Wu Chun, Sheng Zhe, Hu Jianhao, Liu Yuyong, Zhang Chengxin, Xu Jinguo. Short- and mid-term outcomes of mitral valve repair vs. replacement in degenerative mitral regurgitation with left ventricular enlargement.. Frontiers in cardiovascular medicine. 2026. DOI: 10.3389/fcvm.2026.1944441.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.